Pharmasset (VRUS -10.7%) shares plunge after Abbott Laboratories (ABT -0.6%) says interim...
Pharmasset (VRUS -10.7%) shares plunge after Abbott Laboratories (ABT -0.6%) says interim results from a study of its rival experimental hepatitis C drug showed high cure rates. During an analyst meeting, Abbott says the results found that patients with the liver infection can be cured without adding interferon to treatment.
From other sites
Video at CNBC.com (Aug 24, 2015)
Video at CNBC.com (Jul 29, 2015)
at CNBC.com (May 22, 2015)
Video at CNBC.com (Feb 3, 2015)
at CNBC.com (Feb 3, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs